Linked Life Data

14760668

Source:http://linkedlifedata.com/resource/pubmed/id/14760668

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2004-2-4
pubmed:abstractText
Approximately 25 per cent of patients with oesophageal cancer who undergo neoadjuvant chemoradiotherapy have no evidence of tumour in the resected specimen (complete pathological response). Those who do not respond have a poor 5-year survival compared with complete responders, regardless of whether or not they undergo surgery. Selecting for surgery only those who have a response to neoadjuvant therapy has the potential to improve overall survival as well as to rationalize the management of non-responders. This study assessed the accuracy of oesophagogastroscopy in this setting.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0007-1323
pubmed:author
pubmed:copyrightInfo
Copyright 2003 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
pubmed:issnType
Print
pubmed:volume
91
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
199-204
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Use of oesophagogastroscopy to assess the response of oesophageal carcinoma to neoadjuvant therapy.
pubmed:affiliation
Upper Gastrointestinal Multidisciplinary Clinic, University of Queensland, Princess Alexandra Hospital, Buranda, Queensland, Australia. wendy.brown@med.monash.edu.au
pubmed:publicationType
Journal Article, Comparative Study